We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
-23.7%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.06B
AUM Growth
-$330M
(-24%)
Cap. Flow
-$1.75M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$1.75M |
Sector Composition
| Rank | Sector | Weight |
|---|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q3 2015 Portfolio in Review
As of Q3 2015, Crestline Management held 1 position worth $1.06B, down 24% from $1.39B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2015: portfolio turnover was 0%. Crestline Management opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
- Crestline Management's biggest Q3 2015 reduction was Juno Therapeutics, Inc., cutting an estimated $1.75M.
- Crestline Management's ten largest holdings make up 100% of its $1.06B portfolio in Q3 2015.
- Crestline Management opened 0 new positions and closed 0 in Q3 2015.
- Crestline Management's portfolio value fell 24% quarter-over-quarter to $1.06B.
Based on Crestline Management's 13F filing for Q3 2015, filed 12 Nov 2015.